In Focus

As technology advances, new types of data like genomic profiling provide a deeper, clearer view of people and their cancer. Our ability to learn from this data puts the promise of truly personalized healthcare within reach.

It’s important to find a job you love. Employee Pino Florio shares his thoughts on what makes a great company and why he chose to return to Canada after working abroad.

Health is at the heart of everything we do at Roche. Find out more about our science-based approach to creating an environmentally-friendly workplace.

Multiple sclerosis affects everyone differently. To show this individuality, we asked Grace and Marie, two people living with MS, to share their stories.

At the start of a new year, many Canadians resolve to improve their fitness. Unfortunately, many don’t follow through. Through our wellness initiatives, we help our employees balance family and work life, and meet their personal goals

There are many questions about this work and common misconceptions that prevent people from participating in clinical trial, so we thought we would take the opportunity to debunk a few common myths.

Yesterday, Roche and nine other Innovative Medicines Canada member companies voluntarily published payments made to Canadian healthcare providers and organizations in 2016. Today, we comment on why we are committed to advancing this framework to help enhance trust and start a discussion about the value we bring to our healthcare system.

As we near the holidays and the end of an important year, we share our views on the trends that have shaped our business in 2017 and helped us live our mission of “doing now what patients need next.”

Cancer impacts us all and everyone should have a say in the development of the Canadian Strategy for Cancer Control. We encourage you to take #30MinutesThatMatter to provide input.

In our first In Focus post, we explain who we are and why Doing now what patients need next stands as our purpose statement.

In today’s job market, recent graduates’ lack of experience is often cited as a reason for youth unemployment. To help overcome this challenge, each year we welcome a group of students into our office to work on teams related to their area of study. As we say farewell and good luck to this year’s summer students, we spoke with Ana-Maria Calixto about her experience in our program.

No parents should have to raise four children in a neighbourhood where they fear for their safety. Thanks to Habitat for Humanity GTA, and the volunteer efforts of our employees, the Botchway’s have a safe and affordable home that they can call their own for years to come.

With the 2017 Invictus Games taking place in Canada, employee Magda Leonowicz talks about what inspired her to volunteer and how adaptive sport can change lives.

Curing cancer demands our best efforts. Dr. Sandra Horning, Head of Global Product Development, shares her thoughts about the importance of creating partnerships that drive innovation.

Ovarian cancer claims the lives of five Canadian women every day. But how do you stop a disease when people aren’t aware it exists? We spoke with Elisabeth Baugh, CEO of Ovarian Cancer Canada, who shared her organization’s journey to building a worldwide community around a misunderstood disease.

A more inclusive workplace means better ideas and better performance. We're proud that our executive team is made up of 65% women. We spoke with a few of them about their careers and how we have generated a culture of female leaders at Roche Canada.

Announcing the 2017 Rewrite Cancer Innovation Challenge winning projects that will help improve the Canadian patient experience as we enter a new era of cancer care.

On one day each year, employees from Roche sites around the world raise money through the Roche Children’s Walk. Aiman Naseer shares her experience visiting communities supported by this initiative.

Access to innovation, job creation, and a strong life sciences ecosystem are necessary for the sustainability of our healthcare system. We’re committed to building a fair, effective and efficient system that meets the needs of Canadians today and tomorrow.

Nearly half of all Canadians are expected to be diagnosed with cancer in their lifetime. In support of friends and family who are fighting or have lost their battle with this disease, members of our team embark on the Ride to Conquer Cancer, a more than 200 km cycling journey to fund cancer research.

Before a medicine or diagnostic can be used, it must undergo a rigorous testing process. In this post we examine clinical trials and their impact on patients.

It’s been 65 years since Watson and Crick described DNA and 15 years since scientists first decoded the human genome. And while we know there is still a lot we don’t understand, we also celebrate how far we’ve come in genetic science and the possibilities personalized medicine holds for the future.

We’re proud to announce our commitment to supporting charities in the communities where we live and work.

Canada is a leader in clinical research, ranking 4th globally. Through innovation in clinical trial design and policies to address existing gaps, we can build on this history of excellence, ultimately improving the health of Canadians and supporting economic growth.

What does it take to be a great leader? Jennifer Cook, Global Head of Clinical Operations (Pharma), Christina Archer, Site Head for PD Clinical Operations, and Heather Graham, Site Head for PD Regulatory, share their perspective.

The recent introduction of biosimilars is changing Canada’s healthcare landscape. We hope to shed some light on what originator biologics and biosimilars are, how they are manufactured and how they are approved for use in patients.

Through partnerships, we can fully realize the potential of great science and the meaningful impact it can have on the lives of Canadians.

Throughout the years, we’ve searched for innovative solutions to common problems, some of which have impacted our world in surprising ways.

New types of Alzheimer’s treatments may soon be available, but the current healthcare system isn’t prepared. We’re exploring challenges and solutions to help ensure Canadians can get timely access.

Our greater understanding of genomics, Big Data, and the untapped insights sitting within digital health records are shifting the boundaries of what is possible in the quest to improve patient care.

An overwhelming number of Canadians support the concept of a national pharmacare program. However, there is little alignment on what a such a program would look like.

Considering multiple treatment options is a crucial step for many lung cancer patients throughout their journey. After Lucy was diagnosed and the standard chemotherapy approach didn’t work, her doctor began looking at immunotherapy to personalize her treatment.

Technology is helping people and their doctors identify and track how multiple sclerosis might be progressing.

As biosimilars enter the oncology treatment landscape there are a host of patient and physician considerations, recently explored in a Canadian Breast Cancer Network whitepaper.